Skip to main content

Table 3 Univariate analysis by prognostic factors for recurrence-free survival

From: Molecular alterations and clinical prognostic factors in resectable non-small cell lung cancer

Prognostic factors

Overall Cohort

EGFRm Cohort

PD-L1 positive Cohort

HR (95%CI)

P value

HR (95%CI)

P value

HR (95%CI)

P value

Smoking

 Never

Ref

 

Ref

 

Ref

 

 Current or former

1.55 (1.03–2.34)

0.033

2.12 (1.15–3.89)

0.015

0.44 (0.15–1.22)

0.117

COPD

 No

Ref

 

Ref

 

Ref

 

 Yes

1.72 (0.98–3.01)

0.054

1.39 (0.43–0.46)

0.572

0.51 (0.11–2.23)

0.375

CEA

  < 3.8 ng/ml

Ref

 

Ref

 

Ref

 

  ≥ 3.8 ng/ml

2.57 (1.57–4.19)

 < 0.001

4.84 (2.23–10.46)

 < 0.001

1.75 (0.55–5.56)

0.339

pT

 pT1

Ref

 

Ref

 

Ref

 

 pT2a

2.02 (1.27–3.20)

0.003

1.91 (1.05–3.46)

0.031

2.44 (0.82–7.29)

0.108

 pT2b

3.73 (2.03–6.85)

 < 0.001

3.80 (1.62–8.97)

0.002

0.94 (0.11–7.92)

0.961

 pT3

3.81 (2.30–6.30)

 < 0.001

2.22 (0.95–5.19)

0.064

3.90 (1.09–13.94)

0.036

 pT4

4.98 (2.42–10.24)

 < 0.001

4.73 (1.41–15.83)

0.012

2.16 (0.25–18.29)

0.477

pN

 pN0

Ref

 

Ref

 

Ref

 

 pN1

3.88 (2.33–6.44)

 < 0.001

2.93 (1.48–5.78)

0.002

2.01 (0.40–10.07)

0.395

 pN2

4.31 (2.18–8.53)

 < 0.001

5.69 (3.08–10.51)

 < 0.001

7.43 (2.72–20.31)

 < 0.001

pStage

 I

Ref

 

Ref

 

Ref

 

 II

3.30 (2.12–5.13)

 < 0.001

2.15 (1.11–4.17)

0.022

7.16 (1.37–37.24)

0.019

 III

6.74 (4.40–10.33)

 < 0.001

6.53 (3.65–11.69)

 < 0.001

14.27 (3.18–64.02)

0.001

Margin

 Negative

Ref

 

Ref

 

Ref

 

 Positive

4.31 (2.18–8.53)

 < 0.001

3.81 (1.52–9.59)

0.004

1.44 (0.18–11.02)

0.724

LVI

 Negative

Ref

 

Ref

 

Ref

 

 Positive

3.28 (2.27–4.74)

 < 0.001

3.22 (1.90–5.43)

 < 0.001

5.96 (1.73–20.51)

0.005

Pleural invasion

 Negative

Ref

 

Ref

 

Ref

 

 Positive

2.35 (1.61–3.42)

 < 0.001

2.18 (1.28–3.71)

0.004

1.58 (0.59–4.18)

0.354

Histology

 Lepidic

Ref

 

Ref

 

Ref

 

 Acinar

2.59 (1.46–4.60)

0.001

3.54 (1.49–8.42)

0.004

0.91 (0.19–4.32)

0.908

 Micropapillary

5.41 (2.29–12.78)

 < 0.001

4.33 (0.87–21.54)

0.073

1.25 (0.23–6.72)

0.789

 Papillary

4.15 (2.02–8.50)

 < 0.001

4.58 (1.62–12.94)

0.004

 

1

 Solid

4.86 (2.27–10.40)

 < 0.001

10.66 (2.97–38.22)

 < 0.001

0.45 (0.072–2.85)

0.401

 Mucinous

2.83 (1.27–6.30)

 < 0.001

6.69 (1.33–33.49)

0.021

0.73 (0.06–8.10)

0.801

EGFR status

 Wild-type

Ref

 

-

 

-

 

 Mutated

0.88 (0.60–1.28)

0.518

-

 

-

 

PDL1 SP263

 Negative

Ref

 

-

 

-

 

  ≥ 1

1.75 (1.03–2.98)

0.036

-

 

-

 
  1. HR Hazard ratio, Ref Reference